Objective: To evaluate the cost-effectiveness of using cephalexin, TMP/SMX, or clindamycin for outpatient empiric therapy of cellulitis, given various likelihoods of infection due to MRSA.
He had numerous evaluations and admissions for recurrent cellulitis. Treatment regimens included courses of ciprofloxacin, vancomycin, and, at the time of presentation, clindamycin, to no avail.